Skip to main content
pharmacy conference

Speakers


J. Lyle Bootman, Ph.D., Sc.D., FAPhA, FAAPS, FACA

J Lyle Bootman

J. Lyle Bootman is senior vice president for health sciences and dean for the University of Arizona College of Pharmacy, where he is professor of pharmacy, medicine, and public health. Founding and executive director of the University of Arizona Center for Health Outcomes and PharmacoEconomic (HOPE) Research, he is also a founding director of the Healthcare Transformation Institute (HTI), President of the American Association of Colleges of Pharmacy, former president of the American Pharmacists Association, and president emeritus of the Pharmacy & Therapeutics Society. He received his pharmacy education at the University of Arizona and his doctorate at the University of Minnesota, completed a clinical pharmacy residency at the National Institutes of Health, and holds honorary doctorates from the University of the Sciences in Philadelphia and the Ohio State University. He has authored more than 285 publications and has been an invited speaker at more than 600 professional healthcare meetings and symposia. He was selected as one of the 50 most influential pharmacists in the U.S. by American Druggist, and has received numerous outstanding scientific achievement awards, most notably from the American Association of Pharmaceutical Scientists and the Academy of Pharmaceutical Science and Research for his research, which pioneered the field of pharmacoeconomics and health outcomes. He has published several books, including the first textbook introducing the Principles of Pharmacoeconomics, translated into seven languages and used in more than 40 countries. His research regarding the outcomes of drug-related morbidity and mortality receives worldwide attention from the professional and public media. He is an elected member of the Institute of Medicine of the National Academies; advises pharmaceutical companies, universities, and health care organizations worldwide; and serves on several boards, including HTI, the Critical Path Institute, Research Corporation Technologies, CMR Institute, First Databank, and Madeira Therapeutics. In 2008 he received the Joseph P. Remington Honor Medal, the highest honor given by the profession of pharmacy to recognize distinguished service and lifetime contributions.


Richard L. Lalonde, Pharm.D., FCP, FAAPS, FCCP

Richard L. LaLonde

Richard Lalonde is Pfizer Inc.'s vice president and global head of clinical pharmacology, as well as head of clinical pharmacology for Pfizer's Primary Care Business Unit. His work focuses on the quantitative application of pharmacokinetic and pharmacodynamic principles to the optimal development and utilization of new drugs in patients. Immediate past president of the American Society for Clinical Pharmacology and Therapeutics, he currently serves on its board of directors and is a fellow of the American College of Clinical Pharmacology, the American Association of Pharmaceutical Scientists, and the American College of Clinical Pharmacy. He was scientific director and head of clinical pharmacology and pharmacokinetics at Phoenix International (now MDS) in Montreal from 1991 to 1998. From 1984 to 1991 he was assistant and then associate (tenured) professor and vice chair for research in the Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee, Memphis. He also worked from 1980 to 1984 at the University of Ottawa Health Sciences Centre. He has served on the Board of Regents of the American College of Clinical Pharmacology and on the editorial boards of Clinical Pharmacology and Therapeutics and Pharmaceutical Research. He has been an invited speaker at national and international meetings of professional societies, universities, the FDA, and NIH, and served on FDA advisory committees. A graduate of the University of Minnesota (Pharm.D.) and the University of Toronto (B.Sc. in pharmacy), he has authored over 120 manuscripts, abstracts, and book chapters.


John L. LaMattina, Ph.D.

John L. LaMattina

A senior partner at PureTech Ventures, John LaMattina is a former senior vice president of Pfizer Inc. and former president of Pfizer Global Research and Development. During his tenure overseeing the drug discovery and development efforts of over 12,000 colleagues in the U.S., Europe, and Asia, Pfizer produced new treatments for cancer, smoking cessation, rheumatoid arthritis, and AIDS. In 30 years at Pfizer he held positions of increasing responsibility for Pfizer Central Research, including vice president of U.S. discovery operations, senior vice president of worldwide discovery operations, and senior vice president of worldwide development. He earned his B.S. in chemistry cum laude from Boston College and his Ph.D. in organic chemistry from the University of New Hampshire, where he worked with Professor Robert E. Lyle. At Princeton University he worked in the laboratory of Professor E. C. Taylor as a National Institutes of Health postdoctoral fellow. He is the author of numerous publications, including Drug Truths: Dispelling the Myths About Pharma R&D, and holds a number of U.S. patents. His awards include the Boston College Alumni Award of Excellence in Science, an Honorary Doctor of Science degree from the University of New Hampshire, and the American Chemical Society's Earle Barnes Award for Leadership in Chemical Research Management. He serves on the boards of trustees of Human Genome Sciences, Inc. and Ligand Pharmaceuticals, Inc., and on the scientific advisory board of Trevena, Inc. His long history of community activities includes current service on the board of trustees of Boston College, where he chairs the Academic Affairs Committee, and past service as president of the board of the Terri Brodeur Breast Cancer Foundation. He lives in Stonington, Connecticut, with his wife, Mary. They have three children.


Todd Semla, Pharm.D., BCPS, FCCP, AGSF

Todd Semla

A leading expert on pharmacotherapy for older adults, Todd Semla is a clinical pharmacy specialist with the U.S. Department of Veterans Affairs Pharmacy Benefits Management Service and an associate professor in the Departments of Medicine and of Psychiatry and Behavioral Sciences at Northwestern University's Feinberg School of Medicine. He is a past president and board chair of the American Geriatrics Society and a past chair of the American College of Clinical Pharmacy's Geriatric Practice and Research Network. The section editor for drugs and pharmacology for the Journal of the American Geriatrics Society, he served on the editorial boards for the Pharmacotherapy Self-Assessment Program V and VI, and was the consulting editor on pharmacotherapy for the fifth and sixth editions of the Geriatrics Review Syllabus. A board-certified pharmacotherapy specialist, he has received numerous research grants and awards and is the author or co-author of more than 80 scientific studies, reports, books, abstracts, and reviews.


Richard B. Silverman, Ph.D.

Richard B Silverman

Richard Silverman is the inventor of LyricaTM, marketed for epilepsy, neuropathic pain, and fibromyalgia. He received his B.S. in chemistry from Penn State in 1968 and his Ph.D. in organic chemistry from Harvard in 1974, following military service. After two years as a NIH postdoctoral fellow with Robert Abeles in enzymology at Brandeis University, he joined the chemistry faculty at Northwestern. In 1986 he became professor of chemistry and of biochemistry. In 2001 he became the McCormick Professor of Teaching Excellence, and since 2004 he has been the John Evans Professor of Chemistry. Recent awards include the 2009 Perkin Medal, induction into the American Chemical Society (ACS) Medicinal Chemistry Hall of Fame (2009), the E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances from the ACS (2011), and Fellow of the ACS (2011). He has published almost 300 research articles, holds 45 domestic and foreign patents, and has written four books.


Marie Smith, Pharm.D.

Marie Smith

Marie Smith is assistant dean for practice and public policy partnerships and Dr. Henry A. Palmer Professor of Community Pharmacy Practice at the University of Connecticut (UConn) School of Pharmacy, where she was head of the Department of Pharmacy Practice from 2006 to 2011. At the UConn Health Center, she is on the executive committee of the Ethel Donaghue Center for Translating Research into Practice and Policy and is a member of the interdisciplinary Bioinformatics Faculty Initiative. She works with health care reform policymakers and stakeholders to address issues involving medication management programs, patient safety, health information technology, and integration of clinical pharmacists in ambulatory care/patient-centered medical home practice settings. She was formerly vice president for e-strategy and integration at Aventis Pharmaceuticals North American Commercial Operations; a senior leader on the ASHP staff; and a faculty member at University of Tennessee Health Science Center, Medical College of Virginia, Eastern Virginia Medical School, and Rutgers University. In the early 1980's, as an ambulatory care clinical pharmacist and educator, she codirected a progressive, primary care pharmacy clinic for an urban, under-served patient population using a collaborative practice model. A graduate of UConn and Medical College of Virginia Schools of Pharmacy, she completed a hospital pharmacy residency at Thomas Jefferson University Hospital, a fellowship in change management at Johns Hopkins University, and post-graduate work in global leadership executive education at the Wharton School (University of Pennsylvania) and INSEAD (France). In 2010, she was elected to the National Academies of Practice as a distinguished pharmacy practitioner. She has had numerous speaking invitations, publications, and consultancies and has served on grant review panels for universities and federal health agencies, on editorial panels, and as a reviewer for pharmacy and health policy publications. She is an active contributor and editorial advisory board member (health policy) for Annals of Pharmacotherapy.

Who should attend?

• Pharmacists

• Pharmaceutical scientists

• Students and faculty of pharmaceutical, basic, and applied sciences

• Any professional with an interest in medication therapies, drug discovery and development, or pharmaceutical care


Registration

Registration is free and open to the public. Register now

Continuing Pharmacy Education Credit is available.


Questions?

Please contact Dr. Bongsup Cho: bcho@uri.edu
P: 401.874.5024

If you have a disability and need an accommodation, please call 401.874.2896 at least three business days in advance. For TTY assistance, please call the R.I. Relay Service at 800.745.5555.